Lisa Rosenbaum.

Lisa Rosenbaum, M .D.: Transitional Chaos or Enduring Harm? The EHR and the Disruption of Medicine A decade ago, a primary care doctor I undone admired appeared to come. His performance had derived not really from rushing between patients but from knowing them therefore well that his charting was effortless and fast. But suddenly he became distracted, losing his grasp on the facts of his individuals’ lives. He slumped around, shirt half-untucked, perpetually pulling a yellowed handkerchief from his pocket to clean his perspiring forehead. Everyone worried he was ill. His problem, however, ended up being the electronic wellness record .

FDA Approves Repatha for RAISED CHLESTEROL: – FRIDAY, Aug. 28, 2015 – – Repatha has been authorized by the U.S. Drug and Food Administration, the second non-statin medication in its course approved to treat high cholesterol. The injected drug, among a fresh class called PCSK9 inhibitors, is sanctioned for those who are unable to reduce levels of the so-called LDL bad cholesterol with statin therapy and exercise, the agency said in a news release. Low-density lipoprotein, known as LDL commonly, accumulates in the bloodstream from natural and meals sources, and is a respected cause of cardiovascular disease.